Ironwood Pharmaceuticals, Inc.
IRWD
$4.31
$0.235.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1,747.03% | 415.90% | 2,629.20% | 1,259.11% | -185.59% |
| Total Depreciation and Amortization | -5.31% | -6.68% | -6.46% | -6.48% | -4.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.79% | -15.52% | -39.40% | 5.11% | -14.33% |
| Change in Net Operating Assets | 54.75% | -537.39% | 4,941.27% | -375.16% | -273.45% |
| Cash from Operations | 518.83% | 42.91% | 22.69% | -45.49% | -79.57% |
| Capital Expenditure | 97.96% | 97.14% | 76.06% | 90.08% | 87.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.96% | 97.14% | 76.06% | 99.19% | 99.82% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -400.00% | -- | -- | 94.55% | 87.69% |
| Issuance of Common Stock | 43.10% | -78.08% | -98.04% | -97.48% | -97.49% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 99.69% | 91.65% |
| Cash from Financing | -375.76% | 100.23% | 100.20% | 89.65% | 78.02% |
| Foreign Exchange rate Adjustments | 144.92% | -579.37% | -928.13% | -539.81% | -723.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.31% | 957.57% | 3,629.82% | 324.49% | 82.18% |